¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Exercise, passive"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • passive shimming
    ¼öµ¿º¸Á¤
  • passive smoking
    °£Á¢Èí¿¬
  • passive transfer
    ¼öµ¿Àü´Þ
  • passive transport
    ¼öµ¿¿î¹Ý
  • reverse passive anaphylaxis
    ¿ª¼öµ¿¾Æ³ªÇʶô½Ã½º
  • assisted exercise
    º¸Á¶¿îµ¿
  • active exercise
    ´Éµ¿¿îµ¿
  • aerobic exercise
    À¯»ê¼Ò¿îµ¿, »ê¼Ò¿îµ¿
  • anaerobic exercise
    ¹«»ê¼Ò¿îµ¿
  • breathing exercise
    È£Èí¿îµ¿
  • dynamic exercise
    µ¿Àû¿îµ¿
  • exercise
    ¿îµ¿
  • exercise hematuria
    ¿îµ¿Ç÷´¢
  • exercise prescription
    ¿îµ¿Ã³¹æ
  • exercise pressor reflex
    ¿îµ¿½Â¾Ð¹Ý»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • passive sensitization
    ¼öµ¿¹Î°¨
  • passive shimming
    ¼öµ¿º¸Á¤
  • passive smoking
    °£Á¢Èí¿¬
  • passive state
    ¼öµ¿»óÅÂ
  • passive transfer
    ¼öµ¿Àü´Þ
  • passive transport
    ¼öµ¿¿î¹Ý
  • passive aggressive personality
    ¼öµ¿°ø°ÝÀΰÝ
  • passive mobility test
    ¼º´ë°¡µ¿°Ë»ç
  • active exercise
    ´Éµ¿¿îµ¿
  • aerobic exercise
    À¯»ê¼Ò¿îµ¿
  • anaerobic exercise
    ¹«»ê¼Ò¿îµ¿
  • assisted exercise
    º¸Á¶¿îµ¿
  • exercise-induced anaphylaxis
    ¿îµ¿À¯µµ¾Æ³ªÇʶô½Ã½º
  • breathing exercise
    È£Èí¿îµ¿
  • dynamic exercise
    µ¿Àû¿îµ¿
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • personality disorder, passive-aggressive
    ¼öµ¿°ø°Ý¼º ÀΰÝÀå¾Ö
  • personality, passive aggresive
    ¼öµ¿°ø°Ý¼º ÀΰÝ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • exercise
    ¿îµ¿(ê¡ÔÑ), üÁ¶(ô÷ðÃ), ¿¬½À
  • exercise prescription
    ¿îµ¿Ã³¹æ(ê¡ÔÑô¥Û°).
  • exercise prescription
    ¿îµ¿Ã³¹æ.
  • exercise prescription
    ¿îµ¿Ã³¹æ
  • exercise program
    ¿îµ¿(ê¡ÔÑ)ÇÁ·Î±×·¥.
  • exercise program
    ¿îµ¿ÇÁ·Î±×·¥.
  • exercise program
    ¿îµ¿ÇÁ·Î±×·¥
  • exercise stress test
    ¿îµ¿ºÎÇϰ˻ç
  • exercise stress test
    ¿îµ¿ºÎÇϰ˻ç(ê¡ÔÑݶùÃËþÞÛ).
  • exercise stress test
    ¿îµ¿ºÎÇϰ˻ç.
  • exercise stress test
    ¿îµ¿ºÎÇϰ˻ç
  • exercise test
    ¿îµ¿°Ë»ç(ê¡ÔÑËþÞÛ).
  • exercise test
    ¿îµ¿°Ë»ç.
  • exercise test
    ¿îµ¿°Ë»ç
  • exercise tolerance
    ¿îµ¿Çã¿ë´É(ê¡ÔÑúÉé»Òö).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SAE serious adverse event; short above-elbow [cast]; specific action exercise; subcortical arteriosclero...
PCA   1) Passive Cutaneous Araphylaxis
  2) Posterior Cerebral Artery
CPC central posterior curve; cerebellar Purkinje cell; cerebral palsy clinic; cerebral performance categ...
CPM central pontine myelinosis; chlorpheniramine maleate; continuous passive motion; critical path metho...
FPM filter paper microscopic [test]; full passive movements
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PHA Passive Haemagglutination
PHN Passive Heymann nephritis
PCA Passive cutaneous anaphylactic
PHA Passive hemagglutination assays
PROM Passive range of motion
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • active exercise program
    Àû±ØÀû ¿îµ¿
  • aerobic exercise
    À¯»ê¼Ò ¿îµ¿
  • ambulatory exercise
    º¸Çà ¿îµ¿
  • controlled exercise test
    Á¶ÀýµÈ ¿îµ¿ °Ë»ç
  • exercise
    ¿îµ¿, üÁ¶, ¿¬½À
    ¹°Ã¼°¡ ½Ã°£ÀÇ °æ°ú¿¡ µû¶ó À§Ä¡¸¦ ¹Ù²Ù´Â ÀÏ. ¸öÀ» ´Ü·ÃÇϰųª °Ç°­À» º¸Á¸Çϱâ À§ÇÏ¿© ¸öÀ» ¿òÁ÷ÀÌ´Â ÀÏ.
  • exercise prosthesis
    ÈÆ·Ã º¸Ã¶¹°
    ÀϹÝÀûÀ¸·Î Ä¡¾Æ°¡ ¾ø°í, ±³ÇÕ Á¢ÃËÇÏÁö ¾ÊÀ¸¸ç ÁöÁö Á¶Á÷ÀÇ ÀçÇü¼ºÀ» µ½±â À§ÇÏ¿© ¾çÃø¿¡ ¼Õ°¡¶ôÀ¸·Î ÁÖ±âÀûÀ¸·Î ÈûÀ» ÁÖ¾î Æ¯È÷ Ä¡Á¶°ñ µ¶±â¸¦ Èí¼öÇϵµ·Ï ÇÏ´Â Àӽà º¸Ã¶ ÀåÄ¡ÀÌ´Ù.
  • exercise stress testing
    ¿îµ¿ºÎÇϰ˻ç
  • exercise therapy
    ¿îµ¿ Ä¡·á
  • exercise tolerance test
    ¿îµ¿ ºÎÇÏ °Ë»ç
  • fixed exercise prosthesis
    °íÁ¤¼º ÈÆ·Ã º¸Ã¶¹°
  • isokinetic exercise
    µî¿îµ¿¼º ¿îµ¿
    ÀÏÁ¤ÇÑ ¼Óµµ·Î ÀÌ·ç¾îÁö´Â µ¿ÀûÀÎ ±Ù Ȱ¼º.
  • isometric exercise
    µîô¼º ¿îµ¿
    ±ÙÀ° ±æÀÌÀÇ º¯È­ ¾øÀÌ ¾ÈÁ¤µÈ ÀúÇ׿¡ ´ëÇØ ÀÌ·ç¾îÁö´Â ±Ù Ȱµ¿ ¿îµ¿. ¿¹¸¦ µé¸é À̸¦ ¾Ç¹«´Â °ÍÀÌ ¿©±â¿¡ ÇØ´çµÉ ¼ö ÀÖ´Ù.
  • isotonic exercise
    µîÀ强 ¿îµ¿
    ±ÙÀ°ÀÌ Âª¾ÆÁöÁö¸¸ ±Ù ¼öÃà·ÂÀº ¾à°£ÀÇ º¯È­µµ ¾ø´Â Ȱµ¿ ¿îµ¿.
  • muscle conditioning exercise
    ±Ù Á¶°ÇÈ­ ¿îµ¿
  • range-of motion exercise
    ¿îµ¿ ¹üÀ§ ³» ¿îµ¿ ¿ä¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
exercise tolerance The exercise capacity of an individual as measured by endurance (maximal exercise duration and/or maximal attained work load) during an exercise test.
(12 Dec 1998)
exercise treadmill A continuous EKG recording of the heart as the patient performs increasing levels of exercise. The exercise treadmill permits the detection of abnormal heart rhythms (arrhythmias) and provides a screening test for the presence of narrowed arteries to the heart (coronary arteries). Narrowing of these arteries can limit the supply of oxygenated blood to the heart muscle during exercise.
(12 Dec 1998)
artificial passive immunity See: acquired immunity.
(05 Mar 2000)
passive Neither spontaneous nor active, not produced by active efforts.
Origin: L. Passivus
(18 Nov 1997)
passive agglutination Agglutination of particles that have been coated with soluble antigen, by antiserum specific for the adsorbed antigen.
Synonym: indirect agglutination.
(05 Mar 2000)
passive-aggressive behaviour Apparently compliant behaviour, with intrinsic obstructive or stubborn qualities, to cover deeply felt aggressive feelings that cannot be more directly expressed.
(05 Mar 2000)
passive-aggressive personality A personality disorder in which aggressive feelings are manifested in passive ways, especially through mild obstructionism and stubbornness.
(05 Mar 2000)
passive-aggressive personality disorder A personality disorder characterised by an indirect resistance to demands for adequate social and occupational performance; anger and opposition to authority and the expectations of others that is expressed covertly by obstructionism, procrastination, stubbornness, dawdling, forgetfulness, and intentional inefficiency.
(12 Dec 1998)
passive anaphylaxis A reaction resulting from inoculation of antigen in an animal previously inoculated intravenously with specific antiserum from another animal, a latent period being required between the two inoculations.
Synonym: antiserum anaphylaxis.
(05 Mar 2000)
passive atelectasis The pulmonary collapse that occurs due to a space-occupying intrathoracic process such as pneumothorax or hydrothorax.
(05 Mar 2000)
passive clot A clot formed in an aneurysmal sac consequent to the cessation or slowing of circulation through the aneurysm.
(05 Mar 2000)
passive congestion Congestion caused by obstruction or slowing of the venous drainage, resulting in partial stagnation of blood in the capillaries and venules.
(05 Mar 2000)
passive cutaneous anaphylaxis An evanescent cutaneous reaction occurring when antibody is injected into a local area on the skin and antigen is subsequently injected intravenously along with a dye. The dye makes the rapidly occurring capillary dilatation and increased vascular permeability readily visible by leakage into the reaction site. Pca is a sensitive reaction for detecting very small quantities of antibodies and is also a method for studying the mechanisms of immediate hypersensitivity.
(12 Dec 1998)
passive cutaneous anaphylaxis test An animal is injected intradermally with antibody (usually IgE) and subsequently challenged intravenously with a mixture of antigen and Evans blue dye 24-48 hours later. A dark blue area indicates a positive reaction due to the leakage of the dye at the site of antigen-antibody reactions.
(05 Mar 2000)
passive diffusion See: facilitated transport.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • passive resister
    ¼Ò±ØÀû ÀúÇ×ÀÚ
  • passive restraint
    ¼öµ¿Àû ¾ÈÀüÀåÄ¡
  • passive sattelite
    ¼öµ¿ À§¼º
  • passive smoking
    °£Á¢ Èí¿¬
  • passive voice
    ¼öµ¿ÅÂ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á